APMA has the resources you need to help you through every step of your career. With detailed information about MIPS and recent coding trends along with compliance guidelines and practice marketing materials, APMA has you covered whether you are just getting started in practice, preparing for retirement, or anywhere in between.
Today's podiatrist has the necessary education and training to treat all conditions of the foot and ankle and plays a key role in keeping America healthy and mobile while helping combat diabetes and other chronic diseases.
Your feet are excellent barometers for your overall health. Healthy feet keep you moving and active. They are quite literally your foundation. In this section, learn more about APMA Seal-approved and accepted products, proper foot care, common foot and ankle conditions, and how your podiatrist can help keep you and your feet healthy.
APMA is the only organization lobbying for podiatrists and their patients on Capitol Hill. As the voice of podiatric medicine to your legislators and regulators, APMA is active on a variety of critical issues affecting podiatry and the entire health-care system.
APMA is working hard to make sure members have access to the most up-to-date information on recent changes to how and what services podiatric physicians can provide to patients via non face-to-face services. As of March 30, the biggest changes for Medicare and Medicare Advantage patient billing are the following:
The March 30 rule changes are retroactively effective for any services provided on or after March 1. For providers who had a Telephone E/M service denied (CT 99441-99443) that was performed after March 1, but before March 30, APMA recommends resubmitting that claim because these changes are retroactive to March 1.
Members can review all of these changes at www.apma.org/EMremote. APMA will share a podcast in the coming days that addresses all of these updates and resources as well.
Private Payer Resource Page
As noted, the CMS-issued guidance and rules only apply to Medicare and Medicare Advantage patients during the COVID-19 crisis. To assist members with changes to coverage for non-face-to-face services under private and commercial payers, APMA has created a resource page with links to the majority of private payers’ policies at www.apma.org/COVID19telehealthprivate.
Please note that coverage varies by individual policy. APMA also anticipates that private payers will update and change these living links, leaving possibly no reference to the previously existing policy. To protect yourself in the case of an audit or denial, APMA recommends members take the following steps:
APMA will add more commercial payer policies as they become available. If you know of a coverage policy for an insurer not listed on this page, please email the APMA Health Policy and Practice Department at healthpolicy.hpp@apma.org.
Medicare Not Covering Injected Manipulated Amniotic and/or Placental Tissue Biologics
—
Learn MoreCMS DMEPOS Site Inspection Tracking Form
—
Learn More11400 Rockville Pike, Suite 220
Rockville, MD 20852
301-581-9200
Contact Us
Copyright © 2024 American Podiatric Medical Association